Key result
Diabetes accelerates CVD via autonomic neuropathy, inflammation, and oxidative stress, requiring comprehensive risk management.
Why the study?
Diabetes mellitus is a major and independent risk factor for cardiovascular disease with complex pathophysiology and unmet needs for adequate cardiovascular protection despite hyperglycemia control.
Diabetes mellitus is an independent risk factor for cardiovascular disease, requiring a multifaceted approach and aggressive control of risk factors beyond just hyperglycemia.
Answers are grounded in this paper and cite their sources.
Supports multifactorial risk control in diabetes; leaves open dominant mechanisms to prioritize targeted therapies.
Diabetes mellitus (DM) is an epidemic which affects close to 100 million patients worldwide; the majority being type 2 diabetes mellitus. The rising incidence has resulted in a proportional increase in the frequency of cardiovascular disease attributable to DM, as revealed by various population-based studies. Over the past 50 years, DM has been shown to be an important and independent risk factor in the development of a variety of cardiac conditions, especially vascular disease, primarily through accelerated atherosclerosis. Diabetic neuropathy is a serious complication of DM, which leads to the impairment of cardiovascular autonomic control. Diabetic cardiac autonomic neuropathy results in heart rate abnormalities, exercise intolerance, orthostatic blood pressure abnormalities, QT interval prolongation, silent ischemia and diabetic cardiomyopathy, all of which lead to increased morbidity and mortality related to diabetes. This conditions remains difficult to diagnose and treat, requiring a multifaceted approach. Inflammation appears to play a central role in accelerating many of the injurious effects of DM on the cardiovascular system. Expression of specific inflammatory markers has been directly linked to some of the known harmful effects of DM on the cardiovascular system, in addition to indirectly potentiating the deleterious effects of other major cardiovascular disease risk factors. Hyperglycemia results in increased intracellular glucose which triggers several pro-inflammatory reactions leading to the production of harmful free radicals and the formation of advanced glycation end products. These have been linked to the development of diabetic atherogenic dyslipidemia, in addition to glycation and loss of the protective effect of high density lipoproteins in diabetic subjects, thereby worsening the atherosclerotic burden in DM. Addressing hyperglycemia, therefore, is only one of many vital components in the treatment of diabetes. Traditional risk factors for heart disease and stroke tend to be further potentiated by the presence of DM, however, even after adequate control of hyperglycemia. Clinical evidence and major clinical guidelines address this conundrum by pointing out unmet needs of adequate cardiovascular protection, and call for aggressive control of risk factors in the diabetic population. J Endocrinol Metab. 2015;5(6):313-320 doi: http://dx.doi.org/10.14740/jem324e
No takes yet. Share an insight, caveat, or question.
Kolakalapudi et al. (2015) conducted a review in Diabetes Mellitus and Cardiovascular Disease. Diabetes mellitus accelerates cardiovascular disease through mechanisms including autonomic neuropathy, inflammation, and oxidative stress, requiring comprehensive management of all cardiovascular risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: